The most influential COVID-19 articles: A systematic review.
Options
BORIS DOI
Publisher DOI
PubMed ID
36816491
Description
BACKGROUND
Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),causative pathogen of coronavirus disease 2019 (COVID-19), has triggered a pandemic with challenges for health care systems around the world. Researchers have studied and published on the subject of SARS-CoV-2 and the disease extensively. What is the significance of articles published, shared and cited in the early stages of such a pandemic?
MATERIALS AND METHODS
A systematic literature search in a time frame of 12 months and analysis rating using Principle Component Analysis (PCA) and Multiple Factor Analysis (MFA) were performed.
RESULTS
The 100 most cited COVID-19 articles were identified. The majority of these articles were from China (n = 54), followed by United States of America (USA) (n = 21) and United Kingdom (UK) (n = 8). All articles were published in high-ranked, peer-reviewed journals, with research focusing onthe the diagnosis, transmission and therapy of COVID-19. The level of evidence of the 100 most cited COVID-19 articles on average was low.
CONCLUSION
In the early stages of a pandemic, new and innovative research can emerge and be highly cited, regardless of the level of evidence.
Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),causative pathogen of coronavirus disease 2019 (COVID-19), has triggered a pandemic with challenges for health care systems around the world. Researchers have studied and published on the subject of SARS-CoV-2 and the disease extensively. What is the significance of articles published, shared and cited in the early stages of such a pandemic?
MATERIALS AND METHODS
A systematic literature search in a time frame of 12 months and analysis rating using Principle Component Analysis (PCA) and Multiple Factor Analysis (MFA) were performed.
RESULTS
The 100 most cited COVID-19 articles were identified. The majority of these articles were from China (n = 54), followed by United States of America (USA) (n = 21) and United Kingdom (UK) (n = 8). All articles were published in high-ranked, peer-reviewed journals, with research focusing onthe the diagnosis, transmission and therapy of COVID-19. The level of evidence of the 100 most cited COVID-19 articles on average was low.
CONCLUSION
In the early stages of a pandemic, new and innovative research can emerge and be highly cited, regardless of the level of evidence.
Date of Publication
2023-03
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
COVID-19 Citations ICU care Intensive care SARS-CoV-2
Language(s)
en
Contributor(s)
Ahmad, Suhaib Js | |
Degiannis, Konstantinos | |
Borucki, Joseph | |
Pouwels, Sjaak | |
Rawaf, David Laith | |
Head, Marion | |
Li, Chun Hei | |
Archid, Rami | |
Ahmed, Ahmed R | |
Lala, Anil | |
Raza, Wasif | |
Mellor, Katie | |
Wichmann, Doerte |
Additional Credits
Universitätsklinik für Notfallmedizin
Series
New microbes and new infections
Publisher
Elsevier
ISSN
2052-2975
Access(Rights)
open.access